Abbott Laboratories (ABT), Millicom International Cellular (TIGO), Rain Oncology (RAIN), and NeoGames (NGMS) Face Rating Downgrades
- May 30th, 2023
- 688 views
Several companies have experienced downgrades in their ratings today:
Abbott Laboratories (NYSE: ABT), a well-known healthcare company, has been downgraded from Overweight to Equal-Weight by Morgan Stanley.
Currently, $ABT is trading at $101.70, reflecting a decline of $1.17 or 1.06%.
Millicom International Cellular S.A. (Nasdaq: TIGO), a telecommunications and media company operating primarily in Latin America, has experienced a downgrade from Overweight to Equal Weight by Barclays.
$TIGO is trading at $16.82 in intraday, indicating a decrease of $1.16 or 6.48%.
Rain Oncology Inc. (Nasdaq: RAIN), a biopharmaceutical company specializing in cancer therapies, has been downgraded from Buy to Neutral by ROTH MKM.
$RAIN is currently trading at $1.07, reflecting a decline of $0.02 or 2.27%.
NeoGames S.A. (Nasdaq: NGMS), a leading provider of online lottery and scratch games, has experienced a downgrade from Outperform to Neutral by Macquarie.
In intraday, $NGMS is trading at $27.20, down $0.07 or 0.24%.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Johnson & Johnson, Charles Schwab, Halliburton: Earnings Preview
January 18th, 2026Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026
Member Login